Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication

Authors:
  • DTD. Thu¨mMler
    D. Thu¨mMler
  • MSM. Schu¨rCh
    M. Schu¨rCh
  • JRJ.-C. Renggli
    J.-C. Renggli
  • AUA. Urwyler
    A. Urwyler
  • HPH. Pargger
    H. Pargger

Abstract
Neuroleptic malignant syndrome is a rare complication when using neuroleptic drugs. We report the case of a patient with severe Parkinson's disease who developed neuroleptic malignant syndrome after withdrawal of his antiParkinsonian medication for elective coronary artery bypass grafting. Sodium dantrolene may be a therapeutic option in severe cases.

This publication has 17 references indexed in Scilit: